Vissing, J, Jacob, S, Fujita, K P, O’Brien, F, Howard, J F, The REGAIN Study Group, Mazia, C G, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D’Hont, A, Tilkin, P, Alves de Siqueira Carvalho, A, Dias Brockhausen, I, Feder, D, Ambrosio, D, César, P, Melo, A P, Martins Ribeiro, R, Rocha, R, Rosa, B B, Veiga, T, da Silva, L A, Andersen, H, Harbo, T, Vinge, L, Krogh, S, Mogensen, A, Vissing, J, Højgaard, J, Witting, N, Autzen, A M O, Pedersen, J & Weiss, M 2020, ' ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab ', Journal of Neurology, vol. 267, pp. 1991-2001 . https://doi.org/10.1007/s00415-020-09770-y JOURNAL OF NEUROLOGY Journal of Neurology Journal of neurology, 267(7), 1991-2001. D. Steinkopff-Verlag
Andersen, H, Mantegazza, R, Wang, J J, O’Brien, F, Patra, K, Howard, J F & The REGAIN Study Group 2019, ' Eculizumab improves fatigue in refractory generalized myasthenia gravis ', Quality of Life Research, vol. 28, no. 8, pp. 2247-2254 . https://doi.org/10.1007/s11136-019-02148-2 Quality of Life Research QUALITY OF LIFE RESEARCH
REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7 The lancet : international edition Younossi, Z M, Ratziu, V, Loomba, R, Rinella, M, Anstee, Q M, Goodman, Z, Bedossa, P, Geier, A, Beckebaum, S, Newsome, P N, Sheridan, D, Sheikh, M Y, Trotter, J, Knapple, W, Lawitz, E, Abdelmalek, M F, Kowdley, K V, Montano-Loza, A J, Boursier, J, Mathurin, P, Bugianesi, E, Mazzella, G, Olveira, A, Cortez-Pinto, H, Graupera, I, Orr, D, Gluud, L L, Dufour, J-F, Shapiro, D, Campagna, J, Zaru, L, MacConell, L, Shringarpure, R, Harrison, S, Sanyal, A J & REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7